---
title: "ZENITH — Zilebesiran (Hypertension) | Amavita Research"
url: https://md.amavitaresearch.com/trials/zenith-zilebesiran
canonical: https://www.amavitaresearch.com/trials/zenith-zilebesiran
schema_type: MedicalTrial
last_updated: 2026-05-12
---

# ZENITH — Zilebesiran

**Phase 3 cardiovascular trial at Amavita Research (Miami).**

- Sponsor: Alnylam Pharmaceuticals
- Protocol: ALN-AGT01-008
- Indication: Hypertension with elevated cardiovascular risk
- Investigational product: Zilebesiran (RNAi therapeutic)

## How to engage

- Sponsors / CROs: srubio@amavita.health · https://www.amavitaresearch.com/contact-sponsor
- Patients (eligibility): (786) 703-5941 · https://www.amavitaresearch.com/contact-patient